Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Patent: 5,298,422

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,298,422

Title:	Myogenic vector systems
Abstract:	The present invention includes a Myogenic vector system (MVS) for the expression of a nucleic acid sequence in myogenic tissue. The MVS contains a promoter, a cassette with the sequence of interest, a 3\' untranslated region (3\' UTR) and contiguous noncoding region (NCR). Further enhancements can include the addition of a leader sequence, intron sequence, initiation codon and specific This invention was partially supported by a grant from the United States government under HL-38401 awarded by the National Institute of Health. The Government has certain rights in the invention.
Inventor(s):	Schwartz; Robert J. (Houston, TX), DeMayo; Franco J. (Houston, TX), O\'Malley; Bert W. (Houston, TX)
Assignee:	Baylor College of Medicine (Houston, TX)
Application Number:	07/789,919
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 5,298,422
Patent Claims:	see list of patent claims

Details for Patent 5,298,422

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Schering	INTRON A	interferon alfa-2b	VIAL	103132	003	1986-06-04	Start Trial	Baylor College of Medicine (Houston, TX)	2039-02-26	RX		search
Schering	INTRON A	interferon alfa-2b	VIAL	103132	002	1986-06-04	Start Trial	Baylor College of Medicine (Houston, TX)	2039-02-26	RX		search
Schering	INTRON A	interferon alfa-2b	VIAL	103132	001	1986-06-04	Start Trial	Baylor College of Medicine (Houston, TX)	2039-02-26	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 5,298,422

Subscribe to access the full database, or Start Trial
Country	Patent Number	Publication Date
World Intellectual Property Organization (WIPO)	9309236	May 13, 1993
United States of America	5756264	May 26, 1998
United States of America	5925564	Jul 20, 1999
Portugal	101042	Feb 28, 1994
Portugal	101042	Nov 30, 1999
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.